Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
OBJECTIVES: The purpose of this study was to validate the lower end of the putative therapeutic range of serum tacrine concentrations of 7-20 ng ml(-1) in the treatment of Alzheimer's disease. METHODS: The relationship between dose, steady-state serum tacrine concentrations and change in MMSE s...
主要な著者: | Roberts, C, Ford, J, Truman, C, Scott, M, Mäkelä, P, Wilcock, G |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1998
|
類似資料
-
Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
著者:: Forsyth, DR, 等
出版事項: (1989) -
Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
著者:: Ford, J, 等
出版事項: (1993) -
TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
著者:: Wilcock, G
出版事項: (1990) -
PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
著者:: Forsyth, D, 等
出版事項: (1989) -
Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
著者:: Ford, J, 等
出版事項: (1993)